Healthtech Startups - Driving Innovations in Healthcare
Technology enabled vertical of healthcare is known as healthtech. This sector has recently seen many startups offering innovative products or services that improve the distribution
Companies increasingly use innovative deal structures to optimize the risk reward metrics in their transactions leading to growing use of complex instruments like earn-outs, structured debt and equity-based derivatives, and several combinations thereof.
While these instruments have emerged as a powerful tool in corporate transaction strategy, the valuation of such complex securities pose a major challenge and often has significant implications. A wide fluctuation in value of such instruments can have significant impact on the Company’s future earnings
Aranca’s complex securities valuation experts use sophisticated models and advanced analytics to help clients understand the implications at pre-transaction decision making stage as well as to meet financial reporting requirements without any audit hassles. Here are some select situations where clients use our services:
"I must compliment you for the outstanding job you did on our PPA assignment. The report was of high quality and you managed to adhere to short time lines. It is difficult to find responsive and knowledgeable firms that can also offer competitive cost advantage."
CFO, A leading CRM Software firm
"Aranca did a very comprehensive job in performing a valuation of our company. The team was extremely responsive and professional. Our investors said that the report that Aranca wrote was among the best that they had seen for any of their portfolio companies."
Finance Head, Aryaka Networks Inc.
"I must compliment you for the outstanding job you did on our PPA assignment. The report was of high quality and you managed to adhere to short time lines. It is difficult to find responsive and knowledgeable firms that can also offer competitive cost advantage."
CFO, Dachis Group
"Thanks for all of your efforts and commitment to our project. The team did a great job in a short period of time, and I really appreciate it! I’ve worked with multiple business valuations firms in my past, and the job that your team did was by far the best."
CFO, Leading US ecommerce platform
"Aranca did a great job on the 409A report for us. The analysis was extremely thorough and the report was of the highest quality. Greatly exceeded expectations! Thank you."
Senior VP & CFO, New Leaf Symbiotics
"We have had a few valuations done by Aranca. [There were] absolutely no problems with the reports; we have a very complicated cap structure and have filed an S-1. The SEC has reviewed and blessed the results and the supporting report. These were done expertly and at a very competitive price."
Partner, Legal Counsel Firm
"We were looking to accurately and effectively assess and evaluate our IP portfolio to commercialize our assets better or raise funds. We needed experts who understood technical aspects of the patents to determine value with respect to the competitive landscape, and also be able to translate it into a comprehensive but easy to understand financial analysis for potential investors and third-parties. That’s why, we chose Aranca because of its blend of strong Intellectual Property research and valuation capabilities.
The Aranca team was extremely professional, thorough and collaborative while working with our in-house team. We were kept in complete sync during the project engagement, as Aranca conducted the technology strength assessment and built a comprehensive valuation report with detailed market analysis and financial forecasts. To our delight, the team went the extra mile to handle our project deftly, and ensured our needs were completely met. We would score Aranca an ’11 out of 10’ for this project."
Stephen Burnett, Co-Founder & CEO, Koolbridge Solar, Inc.
Technology enabled vertical of healthcare is known as healthtech. This sector has recently seen many startups offering innovative products or services that improve the distribution
A Secondary sale can have serious and far-reaching implications on the pricing of stock options due to 409A provisions. While the extent of the impact
It is a challenge to apply the market-based approach while valuing companies showcasing high inorganic growth or participating in an acquisitive industry. Analysts should be
The defense technology (defense tech) sector has emerged as a resilient and vital area of innovation, especially in 2024, despite an overall slowdown in venture capital
A Veterinary Partner in the USA acquired 41 veterinary clinics and 3 pet boarding facilities in a single transaction, Aranca navigated complex valuation issues with expertise. They
Financial Accounting Standard (FAS) 141 was first implemented in 2001. It is now codified as ASC 805, Business Combinations. Business combinations mean the acquisition of one company by
As we enter a phase of consolidation, mergers and acquisitions have become a vital component of inorganic growth strategies. Post-transaction, it is crucial for the
Early-stage venture-capital-backed businesses are often characterized by their focus on growth, scalability, disruption, and technological invention, all of which result in significant cash burns. It
The cost of equity capital is a critical metric that plays a pivotal role in capital budgeting decisions, optimizing capital structure, and accurately valuing a
As GCC countries start looking at the real impact of the coming Value Added Tax (VAT), planned for the beginning of 2018, the country of Oman
The Narendra Modi government’s decision to replace the Rs500 and Rs1,000 denomination notes with new ones has done in two days what Indian internet s
Three global indices are considering including China's onshore bonds on their indices, which has the potential for strong capital inflows.Talks are underway between China
© , Aranca. All rights reserved.